Page last updated: 2024-08-16

quipazine and quinoline

quipazine has been researched along with quinoline in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bach, A; Bucciarelli, S; Gotfredsen, CH; Høj, LJ; Langkilde, AE; Meier, S; Narayanan, D; Sattler, M; Softley, C; Solbak, SMØ; Zang, J1
Anzini, M; Bruni, G; Cappelli, A; De Benedetti, PG; Doucet, E; Hamon, M; Langer, T; Makovec, F; Mennuni, L; Menziani, MC; Romeo, MR; Vomero, S1

Other Studies

2 other study(ies) available for quipazine and quinoline

ArticleYear
Developing Inhibitors of the p47phox-p22phox Protein-Protein Interaction by Fragment-Based Drug Discovery.
    Journal of medicinal chemistry, 2020, 02-13, Volume: 63, Issue:3

    Topics: Azoles; Drug Discovery; Humans; Indoles; Isoindoles; Molecular Structure; NADPH Oxidase 2; NADPH Oxidases; Organoselenium Compounds; Protein Binding; Structure-Activity Relationship

2020
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.
    Journal of medicinal chemistry, 1998, Feb-26, Volume: 41, Issue:5

    Topics: Animals; Benzene; Binding Sites; Glioma; Guanidine; Mice; Models, Molecular; Molecular Structure; Neuroblastoma; Phenanthridines; Piperazines; Quinolines; Quipazine; Rats; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship; Tumor Cells, Cultured

1998